	Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma. Korean J Radiol Huang PH, Ou HY, Tsang LC, Hsu HW, Lim WX, Huang TL, Weng CC, Lu Y, Hsu CC, Chen CL, Yu CY, Cheng YF. PMID: 42683641 [PubMed - indexed for MEDLINE]
	Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling. Front Immunol Liu Z, Liu J, Xu S, Zhong Y, He KJ, Lu Z, Zheng Y, Zhang Y, Guo Q, Chu H. PMID: 42683268 [PubMed - indexed for MEDLINE]
	The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study. Front Immunol Li X, Dong Y, Chen W, Wang Y, Sun P, Chang X, Wu C, Wang D. PMID: 42682768 [PubMed - indexed for MEDLINE]
	Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial. Front Immunol Liang X, Li Y, Liang M, Zeng Z, Hu K, Yang L, Yan H, Li M, Zeng J, Tang J, Lv Y, Liang L, Meng J, Su H, Ma J, Mo N. PMID: 42682622 [PubMed - indexed for MEDLINE]
	Integrative Multi-Omics Mendelian Randomization Analysis Identifies NIT2 as a Potential Metabolic Risk Gene in Hepatocellular Carcinoma. J Gene Med Liao Z, Fang Q, Chen Y, Yang X, Wu H, Wang H, Gao J. PMID: 42681890 [PubMed - indexed for MEDLINE]
	Focal nodular hyperplasia: a rare benign liver tumour in early childhood without predisposing factors. BMJ Case Rep Agarwal N, Kumar T, Mathew P, Kumar B. PMID: 42680507 [PubMed - indexed for MEDLINE]
	Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for (90)Y Radioembolization with Immunotherapy in HCC. Radiology Avritscher R, Kim E, Chew V, Abou-Alfa GK, Kaseb A, Toskich B, Gade T, Mendiratta-Lala M, Krishnan S, Kappadath SC, Salem R. PMID: 42678260 [PubMed - indexed for MEDLINE]
	Measuring quality of life in advanced chronic liver disease with FACT-Hep: Findings from the PAL LIVER trial. Hepatol Commun Verma M, John BV, Rockey D, Barritt S, Navarro V, Shaw LK, Kosinski A, Tapper EB, Desai A. PMID: 42678241 [PubMed - indexed for MEDLINE]
	Roles of exosome-mediated macrophage polarization in the hepatocellular carcinoma progression. Front Immunol Chen A, Zhu M. PMID: 42676581 [PubMed - indexed for MEDLINE]
	Prognostic Impact of Arterial Phase Hyperenhancement After Proton Beam Therapy for Untreated Solitary Hepatocellular Carcinoma. Cancer Med Niitsu H, Mizumoto M, Li Y, Harada M, Sawada T, Goto M, Sumiya T, Baba K, Fujisawa T, Nakamura M, Ishida T, Iizumi T, Saito T, Numajiri H, Nakai K, Oshiro Y, Sakurai H. PMID: 42675808 [PubMed - indexed for MEDLINE]
	Antiproteinuric Effect of SGLT2 Inhibitors in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab. Anticancer Res Hori T, Yamamoto K, Aoi H, Koizumi Y, Kuromatsu M, Fukui A, Okamoto H, Hirata A, Shinmori K, Imanaka Y, Namba M, Kitamura S, Nakanishi K, Tsushima H, Yano I, Moriya K, Matsui M, Ikushima S. PMID: 42674726 [PubMed - indexed for MEDLINE]
	MMP-2 rs243865 Polymorphism as a Risk Modifier of Hepatocellular Carcinoma in Taiwanese Males, Smokers and Alcohol Consumers. Anticancer Res Yueh TC, Wu MH, Yang MD, Lu MC, Shao YC, Ke TW, Wang ZH, Chen CA, Tsai CW, Bau DT, Chang WS. PMID: 42674711 [PubMed - indexed for MEDLINE]
	Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Res Kuwano A, Yada M, Tanaka K, Hamamoto T, Tanaka R, Kurosaka K, Suzuki H, Motomura K. PMID: 42674706 [PubMed - indexed for MEDLINE]
	Impact of Cirrhosis Outcome Risk Estimator (CORE) Risk Score on Prognosis Following Hepatectomy for Hepatocellular Carcinoma. Anticancer Res Takagi K, Nishiyama T, Kimura J, Fuji T, Yasui K, Fujiwara T. PMID: 42674693 [PubMed - indexed for MEDLINE]
	Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab. Anticancer Res Omori M, Komatsu S, Tada T, Ishihara N, Matsuura T, Ueshima E, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yanagimoto H, Sofue K, Kodama Y, Fukumoto T. PMID: 42674689 [PubMed - indexed for MEDLINE]
	Repeat Hepatectomy Versus Thermal Ablation for Intrahepatic Recurrence After Resection of Colorectal Liver Metastases: A Propensity-adjusted Analysis With Multiple Imputation. Anticancer Res Ikuta S, Aihara T, Nakajima T, Iwasaki T, Yamanaka N. PMID: 42674686 [PubMed - indexed for MEDLINE]
	Lesion-level Quantitative Post-therapy SPECT/CT During (177)Lu-DOTATATE PRRT for NET Liver Metastases. Anticancer Res Konishi K, Wakabayashi K, Ikenohira T, Yamashita R, Aramaki S, Ito S, Nakamura K. PMID: 42674685 [PubMed - indexed for MEDLINE]
	A Case of Concurrent Liver Metastases from Colorectal and Breast Cancer Diagnosed Using Percutaneous Tumor Biopsy. Anticancer Res Yusa T, Masuda T, Tomiguchi M, Nagayama Y, Miyamoto H, Komohara Y, Takematsu T, Adachi Y, Oda E, Ishiko T, Beppu T. PMID: 42674684 [PubMed - indexed for MEDLINE]
	Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study. J Vis Exp Hu QQ, Song ZJ, Shen NT, Jin W, Wu ML, Wu SW. PMID: 42667221 [PubMed - indexed for MEDLINE]
	FOXO6 as a Transcriptional Regulator of Hepatic Metabolic Inflammation and Hepatocarcinogenesis. IUBMB Life Kim ME, Kim Y, Lee JS. PMID: 42665991 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77345

Page 1 of 3868



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy